Arnold SV, Jang JS, Tang F, Graham G, Cohen DJ, Spertus JA. Prediction of residual angina after percutaneous coronary intervention. Eur Heart J Qual Care Clin Outcomes. 2015 Jul 1;1(1):23-30. doi: 10.1093/ehjqcco/qcv010.
Morehouse HA, Wilson DJ, Cannon CP, Manoso MW. Conventional Chondrosarcoma Diagnosed After Total Knee Arthroplasty: A Case Report. JBJS Case Connect. 2015 Oct-Dec;5(4):e104. doi: 10.2106/JBJS.CC.O.00022.
Mandawat A, McCullough SA, Gilstrap LG, Yeh RW. Successful treatment of flecainide overdose with sustained mechanical circulatory support. HeartRhythm Case Rep. 2015 Apr 17;1(3):137-140. doi: 10.1016/j.hrcr.2015.01.003. eCollection 2015 May.
Chirita-Emandi A, Doros G, Simina IJ, Gafencu M, Puiu M. HEAD CIRCUMFERENCE REFERENCES FOR SCHOOL AGE CHILDREN IN WESTERN ROMANIA. Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1083-91.
Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L; EVEREST II Investigators. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015 Dec 29;66(25):2844-2854. doi: 10.1016/j.jacc.2015.10.018.
Jackson LR 2nd, Ju C, Zettler M, Messenger JC, Cohen DJ, Stone GW, Baker BA, Effron M, Peterson ED, Wang TY. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. JACC Cardiovasc Interv. 2015 Dec 21;8(14):1880-9. doi: 10.1016/j.jcin.2015.08.018.
Kadakia MB, Rao SV, McCoy L, Choudhuri PS, Sherwood MW, Lilly S, Kobayashi T, Kolansky DM, Wilensky RL, Yeh RW, Giri J. Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy. JACC Cardiovasc Interv. 2015 Dec 21;8(14):1868-76. doi: 10.1016/j.jcin.2015.07.028.
Naji DI, Chhatriwalla A, Cohen DJ, Main ML. Transapical aortic valve replacement complicated by periaortic hematoma. Echo Res Pract. 2015 Sep 1;2(3):I13-I14. doi: 10.1530/ERP-15-0016. Epub 2015 Jun 30.
Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ, Bruckert E, Jacobson TA, Kopecky SL, Baccara-Dinet MT, Du Y, Pordy R, Gipe DA; ODYSSEY ALTERNATIVE Investigators. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol. 2015 Nov-Dec;9(6):758-769. doi: 10.1016/j.jacl.2015.08.006. Epub 2015 Aug 29.
Magnuson EA, Vilain K, Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, Cohen DJ; ENGAGE AF–TIMI 48 Trial Investigators. Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial. Am Heart J. 2015 Dec;170(6):1140-50. doi: 10.1016/j.ahj.2015.09.011. Epub 2015 Sep 25.
Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. Am Heart J. 2015 Dec;170(6):1061-9. doi: 10.1016/j.ahj.2015.09.007. Epub 2015 Sep 16.
Klann JG, Phillips LC, Turchin A, Weiler S, Mandl KD, Murphy SN. A numerical similarity approach for using retired Current Procedural Terminology (CPT) codes for electronic phenotyping in the Scalable Collaborative Infrastructure for a Learning Health System (SCILHS). BMC Med Inform Decis Mak. 2015 Dec 11;15:104. doi: 10.1186/s12911-015-0223-x.
Murphy TP, Cooper CJ, Matsumoto AH, Cutlip DE, Pencina KM, Jamerson K, Tuttle KR, Shapiro JI, D’Agostino R, Massaro J, Henrich W, Dworkin LD. Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient. J Am Coll Cardiol. 2015 Dec 8;66(22):2487-94. doi: 10.1016/j.jacc.2015.09.073.
Arnold SV, Spertus JA, Vemulapalli S, Dai D, O’Brien SM, Baron SJ, Kirtane AJ, Mack MJ, Green P, Reynolds MR, Rumsfeld JS, Cohen DJ. Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry. Circ Cardiovasc Interv. 2015 Dec;8(12):e002875. doi: 10.1161/CIRCINTERVENTIONS.115.002875.
Lew RA, Liang MH, Doros G. Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier. Arthritis Res Ther. 2015 Dec 4;17:345. doi: 10.1186/s13075-015-0874-0.
Bruckel J, Wagle N, O’Brien C, Elias J, McKenna S, Meyers P, Fifer MA, Pomerantsev E, Yeh RW. Feasibility of a Tablet Computer System to Collect Patient-reported Symptom Severity in Patients Undergoing Diagnostic Coronary Angiography. Crit Pathw Cardiol. 2015 Dec;14(4):139-45. doi: 10.1097/HPC.0000000000000058.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9.
Rao SV, Zeymer U, Douglas PS, Al-Khalidi H, Liu J, Gibson CM, Harrison RW, Joseph DS, Heyrman R, Krucoff MW. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial. Am Heart J. 2015 Nov;170(5):929-37. doi: 10.1016/j.ahj.2015.08.017. Epub 2015 Aug 24.
Jang JS, Spertus JA, Arnold SV, Shafiq A, Grodzinsky A, Fendler TJ, Salisbury AC, Tang F, McNulty EJ, Grantham JA, Cohen DJ, Amin AP. Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. J Am Coll Cardiol. 2015 Nov 10;66(19):2104-2113. doi: 10.1016/j.jacc.2015.08.873.
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Mortality risk with dual antiplatelet therapy?. Lancet. 2015 Oct 17;386(10003):1533-4. doi: 10.1016/S0140-6736(15)00486-9.
Sniderman AD, D’Agostino RB Sr, Pencina MJ. Risk Prediction for Individuals–Reply. JAMA. 2015 Nov 3;314(17):1875-6. doi: 10.1001/jama.2015.12221.
Yeh RW, Kereiakes DJ, Mauri L. Reply: Analysis of Dual Antiplatelet Therapy. J Am Coll Cardiol. 2015 Nov 3;66(18):2056. doi: 10.1016/j.jacc.2015.08.855.
Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ; CoreValve U.S. Pivotal Trial Clinical Investigators. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging. 2015 Dec;8(12):1364-1375. doi: 10.1016/j.jcmg.2015.07.012. Epub 2015 Oct 26.
Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E; BELT Investigators. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. JAMA. 2015 Oct 27;314(16):1720-30. doi: 10.1001/jama.2015.13277.
Safley DM, Venkitachalam L, Kennedy KF, Cohen DJ. Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2015 Oct;8(12):1574-82. doi: 10.1016/j.jcin.2015.04.031.
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026.
Moreira CC, Farber A, Rybin D, Doros G, Kalish J, Eberhardt RT, Siracuse JJ, Hamburg NM. Racial Differences in Treatment Approaches and Mortality Following Arterial Trauma. Vasc Endovascular Surg. 2015 Oct;49(7):180-7. doi: 10.1177/1538574415607360. Epub 2015 Oct 20.
Wimmer NJ, Mauri L. Renal Denervation: Where to Now?. Curr Cardiol Rep. 2015 Dec;17(12):116. doi: 10.1007/s11886-015-0675-8.
Navar-Boggan AM, Peterson ED, D’Agostino RB Sr, Neely B, Sniderman AD, Pencina MJ. Response to Letter Regarding Article, “Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease”. Circulation. 2015 Oct 20;132(16):e203. doi: 10.1161/CIRCULATIONAHA.115.017048.
Ferencik M, Liu T, Mayrhofer T, Puchner SB, Lu MT, Maurovich-Horvat P, Pope JH, Truong QA, Udelson JE, Peacock WF, White CS, Woodard PK, Fleg JL, Nagurney JT, Januzzi JL, Hoffmann U. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial. JACC Cardiovasc Imaging. 2015 Nov;8(11):1272-1281. doi: 10.1016/j.jcmg.2015.06.016. Epub 2015 Oct 14.
Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR; IN.PACT SFA Trial Investigators. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. J Am Coll Cardiol. 2015 Dec 1;66(21):2329-2338. doi: 10.1016/j.jacc.2015.09.063. Epub 2015 Oct 14.
Wasfy JH, Hidrue MK, Yeh RW, Armstrong K, Dec GW Jr, Pomerantsev EV, Fifer MA, Ferris TG. Differences Among Cardiologists in Rates of Positive Coronary Angiograms. J Am Heart Assoc. 2015 Oct 16;4(10):e002393. doi: 10.1161/JAHA.115.002393.
Gao R, Yang Y, Han Y, Huo Y, Chen J, Yu B, Su X, Li L, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Xu B, Popma JJ, Stone GW; ABSORB China Investigators. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. J Am Coll Cardiol. 2015 Dec 1;66(21):2298-2309. doi: 10.1016/j.jacc.2015.09.054. Epub 2015 Oct 12.
Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.
Walkey AJ, Pencina KM, Knox D, Kuttler KG, D’Agostino RB Sr, Benjamin EJ, Brown SM. Five-Year Risk of Mechanical Ventilation in Community-Dwelling Adults: The Framingham-Intermountain Anticipating Life Support Study. J Am Geriatr Soc. 2015 Oct;63(10):2082-8. doi: 10.1111/jgs.13673. Epub 2015 Oct 12.
Waldo SW, Chang L, Strom JB, O’Brien C, Pomerantsev E, Yeh RW. Predicting the Presence of an Acute Coronary Lesion Among Patients Resuscitated From Cardiac Arrest. Circ Cardiovasc Interv. 2015 Oct;8(10):e002198. doi: 10.1161/CIRCINTERVENTIONS.114.002198.
Andell P, James SK, Cannon CP, Cyr DD, Himmelmann A, Husted S, Keltai M, Koul S, Santoso A, Steg PG, Storey RF, Wallentin L, Erlinge D; PLATO Investigators. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Heart Assoc. 2015 Oct 9;4(10):e002490. doi: 10.1161/JAHA.115.002490.
Cannon CP, Blazing MA, Braunwald E. Ezetimibe plus a Statin after Acute Coronary Syndromes. N Engl J Med. 2015 Oct 8;373(15):1476-7. doi: 10.1056/NEJMc1509363.
Brunner-La Rocca HP, Eurlings L, Richards AM, Januzzi JL, Pfisterer ME, Dahlström U, Pinto YM, Karlström P, Erntell H, Berger R, Persson H, O’Connor CM, Moertl D, Gaggin HK, Frampton CM, Nicholls MG, Troughton RW. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials. Eur J Heart Fail. 2015 Dec;17(12):1252-61. doi: 10.1002/ejhf.401. Epub 2015 Sep 30.
Teixeira A, Parenica J, Park JJ, Ishihara S, AlHabib KF, Laribi S, Maggioni A, Miró Ò, Sato N, Kajimoto K, Cohen-Solal A, Fairman E, Lassus J, Mueller C, Peacock WF, Januzzi JL Jr, Choi DJ, Plaisance P, Spinar J, Mebazaa A, Gayat E; GREAT (Global Research on Acute Conditions Team) Network. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail. 2015 Nov;17(11):1114-23. doi: 10.1002/ejhf.330. Epub 2015 Sep 30.
Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Response to letters regarding article, “prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement”. Circulation. 2015 Sep 29;132(13):e166-7. doi: 10.1161/CIRCULATIONAHA.115.016779.
Arias EJ, Vajapey S, Reynolds MR, Chicoine MR, Rich KM, Dacey RG Jr, Dorward IG, Derdeyn CP, Moran CJ, Cross DT 3rd, Zipfel GJ, Dhar R. Utility of Screening for Cerebral Vasospasm Using Digital Subtraction Angiography. Stroke. 2015 Nov;46(11):3137-41. doi: 10.1161/STROKEAHA.115.010081. Epub 2015 Sep 24.
Waldo SW, Secemsky EA, O’Brien C, Kennedy KF, Pomerantsev E, Sundt TM 3rd, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, “Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention”. Circulation. 2015 Sep 22;132(12):e156. doi: 10.1161/CIRCULATIONAHA.115.016777.
Chhatriwalla AK, Venkitachalam L, Kennedy KF, Stolker JM, Jones PG, Cohen DJ, Spertus JA. Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction. Am Heart J. 2015 Oct;170(4):796-804.e3. doi: 10.1016/j.ahj.2015.07.021. Epub 2015 Jul 26.
Kereiakes DJ, Ellis SG, Popma JJ, Fitzgerald PJ, Samady H, Jones-McMeans J, Zhang Z, Cheong WF, Su X, Ben-Yehuda O, Stone GW. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial. Am Heart J. 2015 Oct;170(4):641-651.e3. doi: 10.1016/j.ahj.2015.07.013. Epub 2015 Jul 26.
Yakubov SJ, Adams DH, Watson DR, Reardon MJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Schreiber T, Gleason TG, Conte J, Deeb GM, Huang J, Oh J, Byrne T, Caskey M, Popma JJ; CoreValve United States Clinical Investigators. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol. 2015 Sep 22;66(12):1327-34. doi: 10.1016/j.jacc.2015.07.042.
Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, D’Agostino R, East C, Katzen BT, Lee L, Leon MB, Mauri L, O’Neill WW, Oparil S, Rocha-Singh K, Townsend RR, Bakris G; SYMPLICITY HTN-3 Investigators. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. J Am Soc Hypertens. 2015 Oct;9(10):769-779. doi: 10.1016/j.jash.2015.08.001. Epub 2015 Aug 8.
Wei GS, Coady SA, Reis JP, Carnethon MR, Coresh J, D’Agostino RB Sr, Goff DC Jr, Jacobs DR Jr, Selvin E, Fox CS. Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care. 2015 Nov;38(11):2042-9. doi: 10.2337/dc14-2770. Epub 2015 Sep 10.
Pencina MJ, D’Agostino RB Sr. Evaluating Discrimination of Risk Prediction Models: The C Statistic. JAMA. 2015 Sep 8;314(10):1063-4. doi: 10.1001/jama.2015.11082.
Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study. J Nerv Ment Dis. 2015 Oct;203(10):762-8. doi: 10.1097/NMD.0000000000000364.
Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metab. 2015 Dec;17(12):1180-93. doi: 10.1111/dom.12572. Epub 2015 Oct 9.
Wulsin L, Horn P, Massaro J, D’Agostino R. Response to the Letter by Masuo R., et al. J Clin Endocrinol Metab. 2015 Sep;100(9):L70. doi: 10.1210/jc.2015-2600.
Yeh RW, Kereiakes DJ, Mauri L. Reply: Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let’s Re-Evaluate Our Priorities. J Am Coll Cardiol. 2015 Sep 8;66(10):1204-5. doi: 10.1016/j.jacc.2015.06.1331.
Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW; ABSORB Japan Investigators. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015 Dec 14;36(47):3332-42. doi: 10.1093/eurheartj/ehv435. Epub 2015 Sep 1.
Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, Tershakovec AM, Blazing MA, Braunwald E. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation. 2015 Sep 29;132(13):1224-33. doi: 10.1161/CIRCULATIONAHA.115.018381. Epub 2015 Sep 1.
Sharma A, Khan JS, Bainey KR. Preoperative Stress Tests–Superfluous Investigations Resulting in Excessive Treatment Delay: A Teachable Moment. JAMA Intern Med. 2015 Oct;175(10):1610-1. doi: 10.1001/jamainternmed.2015.4420.
Mays AC, Worley M, Ackall F, D’Agostino R Jr, Waltonen JD. The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients. Surg Oncol. 2015 Sep;24(3):248-57. doi: 10.1016/j.suronc.2015.08.005. Epub 2015 Aug 12.
Eslami MH, Rybin DV, Doros G, Farber A. The Association of Publication of Center for Medicaid and Medicare Services Guidelines for Carotid Artery Angioplasty and Stenting (CAS) and CREST Results on the Utilization of CAS in Carotid Revascularization. Ann Vasc Surg. 2015 Nov;29(8):1606-13. doi: 10.1016/j.avsg.2015.06.091. Epub 2015 Aug 24.
Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ; CoreValve US Pivotal Trial Investigators. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.
Hunter DJ, D’Agostino RB Sr. Let’s Not Put All Our Eggs in One Basket. N Engl J Med. 2015 Aug 20;373(8):691-3. doi: 10.1056/NEJMp1508144.
Wasfy JH, Singal G, O’Brien C, Blumenthal DM, Kennedy KF, Strom JB, Spertus JA, Mauri L, Normand SL, Yeh RW. Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record. Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):477-85. doi: 10.1161/CIRCOUTCOMES.115.001855. Epub 2015 Aug 18.
Rosas HD, Doros G, Bhasin S, Thomas B, Gevorkian S, Malarick K, Matson W, Hersch SM. A systems-level “misunderstanding”: the plasma metabolome in Huntington’s disease. Ann Clin Transl Neurol. 2015 Jul;2(7):756-68. doi: 10.1002/acn3.214. Epub 2015 May 28.
Vodovar N, Séronde MF, Laribi S, Gayat E, Lassus J, Januzzi JL Jr, Boukef R, Nouira S, Manivet P, Samuel JL, Logeart D, Cohen-Solal A, Richards AM, Launay JM, Mebazaa A; GREAT Network. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure. JACC Heart Fail. 2015 Aug;3(8):629-36. doi: 10.1016/j.jchf.2015.03.011.
Januzzi JL Jr, Mann DL. Light Chains and the Failing Heart: Important Mechanistic Link or Fifty Shades of Gray?. JACC Heart Fail. 2015 Aug;3(8):626-8. doi: 10.1016/j.jchf.2015.03.012.
Thourani VH, Jensen HA, Babaliaros V, Kodali SK, Rajeswaran J, Ehrlinger J, Blackstone EH, Suri RM, Don CW, Aldea G, Williams MR, Makkar R, Svensson LG, McCabe JM, Dean LS, Kapadia S, Cohen DJ, Pichard AD, Szeto WY, Herrmann HC, Devireddy C, Leshnower BG, Ailawadi G, Maniar HS, Hahn RT, Leon MB, Mack M. Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. Ann Thorac Surg. 2015 Sep;100(3):785-92; discussion 793. doi: 10.1016/j.athoracsur.2015.05.021. Epub 2015 Aug 1.
Allen KB, Johnson LM, Borkon AM, Aggarwal S, Davis JR, Cohen DJ, Chhatriwalla AK, Grantham A, Hart A. Combined Transcatheter Aortic Valve Replacement and Thoracic Endovascular Aortic Repair Using Transapical Access. Ann Thorac Surg. 2015 Aug;100(2):723-7. doi: 10.1016/j.athoracsur.2014.10.024.
Thourani VH, Jensen HA, Babaliaros V, Suri R, Vemulapalli S, Dai D, Brennan JM, Rumsfeld J, Edwards F, Tuzcu EM, Svensson L, Szeto WY, Herrmann H, Kirtane AJ, Kodali S, Cohen DJ, Lerakis S, Devireddy C, Sarin E, Carroll J, Holmes D, Grover FL, Williams M, Maniar H, Shahian D, Mack M. Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Ann Thorac Surg. 2015 Nov;100(5):1718-26; discussion 1726-7. doi: 10.1016/j.athoracsur.2015.05.010. Epub 2015 Jul 29.
Putt M, Hahn VS, Januzzi JL, Sawaya H, Sebag IA, Plana JC, Picard MH, Carver JR, Halpern EF, Kuter I, Passeri J, Cohen V, Banchs J, Martin RP, Gerszten RE, Scherrer-Crosbie M, Ky B. Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab. Clin Chem. 2015 Sep;61(9):1164-72. doi: 10.1373/clinchem.2015.241232. Epub 2015 Jul 27.
Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, Januzzi JL Jr, Vasan RS, Seshadri S. Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke. Stroke. 2015 Sep;46(9):2568-75. doi: 10.1161/STROKEAHA.115.009026. Epub 2015 Jul 28.
Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right. Clin Cardiol. 2015 Aug;38(8):447-54. doi: 10.1002/clc.22424. Epub 2015 Jul 27.
Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Kouchoukos NT, Peterson ED, Alexander JH. Response to Letters Regarding Article, “Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV”. Circulation. 2015 Jul 28;132(4):e29. doi: 10.1161/CIRCULATIONAHA.115.015362.
Reed GW, Guo J, Cannon CP, Kumar A, Aranki S, Shekar P, Agnihotri A, Maree AO, McLean DS, Rosenfield K. Authors’ Reply. Clin Cardiol. 2015 Jul;38(7):444-5. doi: 10.1002/clc.22413.
Reynolds MR, Buckley RT, Indrakanti SS, Turkmani AH, Oh G, Crobeddu E, Fargen KM, El Ahmadieh TY, Naidech AM, Amin-Hanjani S, Lanzino G, Hoh BL, Bendok BR, Zipfel GJ. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms. J Neurosurg. 2015 Oct;123(4):862-71. doi: 10.3171/2014.12.JNS141201. Epub 2015 Jul 24.
Chyou JY, Hunter TD, Mollenkopf SA, Turakhia MP, Reynolds MR. Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients. J Am Heart Assoc. 2015 Jul 23;4(7):e001723. doi: 10.1161/JAHA.114.001723.
Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL; ACC/AHA TASK FORCE ON CLINICAL DATA STANDARDS MEMBERS. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Nucl Cardiol. 2015 Oct;22(5):1041-144. doi: 10.1007/s12350-015-0209-1.
Ibrahim N, Januzzi JL. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Expert Rev Cardiovasc Ther. 2015;13(9):1017-30. doi: 10.1586/14779072.2015.1071664. Epub 2015 Jul 21.
Nzara R, Rybin D, Doros G, Didato S, Farber A, Eslami MH, Kalish JA, Siracuse JJ. Perioperative Outcomes in Patients Requiring Iliac Conduits or Direct Access for Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2015 Nov;29(8):1548-53. doi: 10.1016/j.avsg.2015.06.065. Epub 2015 Jul 18.
Kramer DB, Cutlip DE. Regulatory science: Trust and transparency in clinical trials of medical devices. Nat Rev Cardiol. 2015 Sep;12(9):503-4. doi: 10.1038/nrcardio.2015.112. Epub 2015 Jul 21.
Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, Lombardi WL, Menon RV, Grantham JA, Kandzari DE, Lembo N, Moses JW, Kirtane AJ, Parikh M, Green P, Finn M, Garcia S, Doing A, Patel M, Bahadorani J, Tarar MN, Christakopoulos GE, Thompson CA, Banerjee S, Brilakis ES. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015 Nov 1;198:222-8. doi: 10.1016/j.ijcard.2015.06.093. Epub 2015 Jun 27.
Matteau A, Yeh RW, Camenzind E, Steg PG, Wijns W, Mills J, Gershlick A, de Belder M, Ducrocq G, Mauri L. Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2015 Sep 1;116(5):686-93. doi: 10.1016/j.amjcard.2015.05.036. Epub 2015 Jun 3.
Eslami MH, Rybin D, Doros G, Kalish JA, Farber A; Vascular Study Group of New England. Comparison of a Vascular Study Group of New England risk prediction model with established risk prediction models of in-hospital mortality after elective abdominal aortic aneurysm repair. J Vasc Surg. 2015 Nov;62(5):1125-33.e2. doi: 10.1016/j.jvs.2015.06.051. Epub 2015 Jul 14.
Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC). Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. J Am Coll Cardiol. 2015 Jul 21;66(3):278-307. doi: 10.1016/j.jacc.2015.05.046.
Xu W, Shubina M, Goldberg SI, Turchin A. Body mass index and all-cause mortality in patients with hypertension. Obesity (Silver Spring). 2015 Aug;23(8):1712-20. doi: 10.1002/oby.21129. Epub 2015 Jul 14.
Pursnani A, Massaro JM, D’Agostino RB Sr, O’Donnell CJ, Hoffmann U. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. JAMA. 2015 Jul 14;314(2):134-41. doi: 10.1001/jama.2015.7515.
Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC). Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. Eur Heart J. 2015 Aug 1;36(29):1851-77. doi: 10.1093/eurheartj/ehv281. Epub 2015 Jul 13.
Huffman JC, Beale EE, Beach SR, Celano CM, Belcher AM, Moore SV, Suarez L, Gandhi PU, Motiwala SR, Gaggin H, Januzzi JL. Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study. Contemp Clin Trials. 2015 Sep;44:11-19. doi: 10.1016/j.cct.2015.07.002. Epub 2015 Jul 10.
Christopoulos G, Wyman RM, Alaswad K, Karmpaliotis D, Lombardi W, Grantham JA, Yeh RW, Jaffer FA, Cipher DJ, Rangan BV, Christakopoulos GE, Kypreos MA, Lembo N, Kandzari D, Garcia S, Thompson CA, Banerjee S, Brilakis ES. Clinical Utility of the Japan-Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry. Circ Cardiovasc Interv. 2015 Jul;8(7):e002171. doi: 10.1161/CIRCINTERVENTIONS.114.002171.
Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O’Keeffe LM, Gao P, Wood AM, Burgess S, Freitag DF, Pennells L, Peters SA, Hart CL, Håheim LL, Gillum RF, Nordestgaard BG, Psaty BM, Yeap BB, Knuiman MW, Nietert PJ, Kauhanen J, Salonen JT, Kuller LH, Simons LA, van der Schouw YT, Barrett-Connor E, Selmer R, Crespo CJ, Rodriguez B, Verschuren WM, Salomaa V, Svärdsudd K, van der Harst P, Björkelund C, Wilhelmsen L, Wallace RB, Brenner H, Amouyel P, Barr EL, Iso H, Onat A, Trevisan M, D’Agostino RB Sr, Cooper C, Kavousi M, Welin L, Roussel R, Hu FB, Sato S, Davidson KW, Howard BV, Leening MJ, Leening M, Rosengren A, Dörr M, Deeg DJ, Kiechl S, Stehouwer CD, Nissinen A, Giampaoli S, Donfrancesco C, Kromhout D, Price JF, Peters A, Meade TW, Casiglia E, Lawlor DA, Gallacher J, Nagel D, Franco OH, Assmann G, Dagenais GR, Jukema JW, Sundström J, Woodward M, Brunner EJ, Khaw KT, Wareham NJ, Whitsel EA, Njølstad I, Hedblad B, Wassertheil-Smoller S, Engström G, Rosamond WD, Selvin E, Sattar N, Thompson SG, Danesh J. Association of Cardiometabolic Multimorbidity With Mortality. JAMA. 2015 Jul 7;314(1):52-60. doi: 10.1001/jama.2015.7008.
Sniderman AD, D’Agostino RB Sr, Pencina MJ. The Role of Physicians in the Era of Predictive Analytics. JAMA. 2015 Jul 7;314(1):25-6. doi: 10.1001/jama.2015.6177.
Goff DC Jr, D’Agostino RB Sr, Pencina M, Lloyd-Jones DM. Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. Ann Intern Med. 2015 Jul 7;163(1):68. doi: 10.7326/L15-5105.
Reynolds MR, Scheiber C, Hajovsky DB, Schwartz B, Kaufman AS. Gender Differences in Academic Achievement: Is Writing an Exception to the Gender Similarities Hypothesis?. J Genet Psychol. 2015 May-Aug;176(3-4):211-34. doi: 10.1080/00221325.2015.1036833. Epub 2015 Jul 2.
Reynolds MR, Roland JL, Kamath AA, Cross DT 3rd, Dacey RG Jr. Microsurgical confirmation of perforating arteries arising from the fundus of a posterior communicating artery aneurysm. Neurosurg Focus. 2015 Jul;39 Video Suppl 1:V16. doi: 10.3171/2015.7.FocusVid.14628.
Reynolds MR, Arias EJ, Chatterjee AR, Chicoine MR, Cross DT 3rd. Acute rupture of a feeding artery aneurysm after embolization of a brain arteriovenous malformation. Interv Neuroradiol. 2015 Oct;21(5):613-9. doi: 10.1177/1591019915591740. Epub 2015 Jun 30.
Khera AV, Qamar A, Murphy SA, Cannon CP, Sabatine MS, Rader DJ. On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study). Am J Cardiol. 2015 Sep 1;116(5):694-8. doi: 10.1016/j.amjcard.2015.05.038. Epub 2015 Jun 4.
Gale HI, Setty BN, Sprinz PG, Doros G, Williams DD, Morrison TC, Kalajian TA, Tu P, Mundluru SN, Mehta MN, Castro-Aragon I. Implications of radiologic-pathologic correlation for gallbladder disease in children and young adults with sickle cell disease. Emerg Radiol. 2015 Oct;22(5):543-51. doi: 10.1007/s10140-015-1326-5. Epub 2015 Jun 25.
Tabtabai S, DeFaria Yeh D, Stefanescu A, Kennedy K, Yeh RW, Bhatt AB. National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy. Am J Cardiol. 2015 Sep 1;116(5):773-8. doi: 10.1016/j.amjcard.2015.05.053. Epub 2015 Jun 4.
Badgett RG, Vindhyal M, Stirnaman JT, Gibson CM, Halaby R. A Living Systematic Review of Nebulized Hypertonic Saline for Acute Bronchiolitis in Infants. JAMA Pediatr. 2015 Aug;169(8):788-9. doi: 10.1001/jamapediatrics.2015.0681.
Garibyan L, Cornelissen L, Sipprell W, Pruessner J, Elmariah S, Luo T, Lerner EA, Jung Y, Evans C, Zurakowski D, Berde CB, Rox Anderson R. Transient Alterations of Cutaneous Sensory Nerve Function by Noninvasive Cryolipolysis. J Invest Dermatol. 2015 Nov;135(11):2623-2631. doi: 10.1038/jid.2015.233. Epub 2015 Jun 22.
Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal denervation for the treatment of hypertension: Making a new start, getting it right. Catheter Cardiovasc Interv. 2015 Nov;86(5):855-63. doi: 10.1002/ccd.26028. Epub 2015 Jun 11.
Tan TW, Eslami M, Rybin D, Doros G, Zhang WW, Farber A. Blood transfusion is associated with increased risk of perioperative complications and prolonged hospital duration of stay among patients undergoing amputation. Surgery. 2015 Dec;158(6):1609-16. doi: 10.1016/j.surg.2015.04.039. Epub 2015 Jun 18.
Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR; CAPTAIN Investigators. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial. Am Heart J. 2015 Jul;170(1):110-6. doi: 10.1016/j.ahj.2015.04.019. Epub 2015 Apr 18.
Saad F, Yassin A, Almehmadi Y, Doros G, Gooren L. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports. Aging Male. 2015;18(3):164-8. doi: 10.3109/13685538.2015.1034687. Epub 2015 Jun 15.
Hosomura N, Goldberg SI, Shubina M, Zhang M, Turchin A. Electronic Documentation of Lifestyle Counseling and Glycemic Control in Patients With Diabetes. Diabetes Care. 2015 Jul;38(7):1326-32. doi: 10.2337/dc14-2016. Epub 2015 Jun 12.
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Dual antiplatelet therapy duration and mortality – Authors’ reply. Lancet. 2015 May 30;385(9983):2149-50. doi: 10.1016/S0140-6736(15)61019-4.
Gada H, Kirtane AJ, Wang K, Lei Y, Magnuson E, Reynolds MR, Williams MR, Kodali S, Vahl TP, Arnold SV, Leon MB, Thourani V, Szeto WY, Cohen DJ; PARTNER Investigators. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy. Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):338-46. doi: 10.1161/CIRCOUTCOMES.114.001335. Epub 2015 Jun 9.
Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14;66(2):113-21. doi: 10.1016/j.jacc.2015.05.017. Epub 2015 Jun 5.
Traish AM, Haider KS, Doros G, Haider A. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Horm Mol Biol Clin Investig. 2015 Sep;23(3):85-96. doi: 10.1515/hmbci-2015-0015.
Folt DA, Evans KL, Brahmandam S, He W, Brewster PS, Yu S, Murphy TP, Cutlip DE, Dworkin LD, Jamerson K, Henrich W, Kalra PA, Tobe S, Thomson K, Holden A, Rayner BL, Grinfeld L, Haller ST, Cooper CJ. Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis. J Am Soc Hypertens. 2015 Jun;9(6):443-52. doi: 10.1016/j.jash.2015.03.007. Epub 2015 Mar 28.
Wulsin LR, Horn PS, Perry JL, Massaro JM, D’Agostino RB. Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality. J Clin Endocrinol Metab. 2015 Jun;100(6):2443-8. doi: 10.1210/jc.2015-1748.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.
Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):437-46. doi: 10.1161/CIRCOUTCOMES.114.001660. Epub 2015 Jun 2.
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Response to letter regarding article, “Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry”. Circulation. 2015 Jun 2;131(22):e518. doi: 10.1161/CIRCULATIONAHA.114.014727.
Vardi M, Cryer BL, Cohen M, Lanas A, Schnitzer TJ, Lapuerta P, Goldsmith MA, Laine L, Doros G, Liu Y, McIntosh AI, Cannon CP, Bhatt DL. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. Aliment Pharmacol Ther. 2015 Aug;42(3):365-74. doi: 10.1111/apt.13260. Epub 2015 May 29.
Kereiakes DJ, Robinson JG, Cannon CP, Lorenzato C, Pordy R, Chaudhari U, Colhoun HM. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. Am Heart J. 2015 Jun;169(6):906-915.e13. doi: 10.1016/j.ahj.2015.03.004. Epub 2015 Mar 13.
Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015 Jun;169(6):833-40. doi: 10.1016/j.ahj.2015.02.022. Epub 2015 Mar 13.
Sarich TC, Seltzer JH, Berkowitz SD, Costin’ J, Curnutte JT, Gibson CM, Hoffman M, Kaminskas E, Krucoff MW, Levy JH, Mintz PD, Reilly PA, Sager PT, Singer DE, Stockbridge N, Weitz JI, Kowey PR. Novel oral anticoagulants and reversal agents: Considerations for clinical development. Am Heart J. 2015 Jun;169(6):751-7. doi: 10.1016/j.ahj.2015.03.010. Epub 2015 Mar 26.
Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart. 2015 Oct;101(20):1631-8. doi: 10.1136/heartjnl-2014-307119. Epub 2015 May 29.
Angiolillo DJ, Bhatt DL, Steg PG, Stone GW, White HD, Gibson CM, Hamm CW, Price MJ, Prats J, Liu T, Mahaffey KW, Harrington RA. Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials. J Thromb Thrombolysis. 2015 Oct;40(3):317-22. doi: 10.1007/s11239-015-1233-3.
Nasser M, Haider A, Saad F, Kurtz W, Doros G, Fijak M, Vignozzi L, Gooren L. Testosterone therapy in men with Crohn’s disease improves the clinical course of the disease: data from long-term observational registry study. Horm Mol Biol Clin Investig. 2015 Jun;22(3):111-7. doi: 10.1515/hmbci-2015-0014.
Saydah SH, Imperatore G, Henkin L, D’Agostino R Jr, Divers J, Mayer-Davis EJ, Dabelea D, Klingensmith G, Pihoker C, Lawrence JM. Trends and characteristics of self-reported case presentation of diabetes diagnosis among youth from 2002 to 2010: findings from the SEARCH for diabetes in youth study. Diabetes Care. 2015 Jun;38(6):e84-5. doi: 10.2337/dc15-0157.
Westcott MM, Liu J, Rajani K, D’Agostino R Jr, Lyles DS, Porosnicu M. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol. 2015 Aug;89(15):7944-54. doi: 10.1128/JVI.00757-15. Epub 2015 May 20.
Elmariah S. Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications. Curr Treat Options Cardiovasc Med. 2015 Jul;17(7):391. doi: 10.1007/s11936-015-0391-0.
Zhang R, Zhang Y, An T, Guo X, Yin S, Wang Y, Januzzi JL, Cappola TP, Zhang J. Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure. Biomark Med. 2015;9(5):433-41. doi: 10.2217/bmm.15.12.
Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, Reynolds MR. Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study. J Am Heart Assoc. 2015 May 15;4(5):e001775. doi: 10.1161/JAHA.115.001775.
White WB, Galis ZS, Henegar J, Kandzari DE, Victor R, Sica D, Townsend RR, Turner JR, Virmani R, Mauri L. Renal denervation therapy for hypertension: pathways for moving development forward. J Am Soc Hypertens. 2015 May;9(5):341-50. doi: 10.1016/j.jash.2015.02.012.
Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right. J Clin Hypertens (Greenwich). 2015 Oct;17(10):743-50. doi: 10.1111/jch.12590. Epub 2015 May 14.
Shimada YJ, Cannon CP. PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future. Eur Heart J. 2015 Sep 21;36(36):2415-24. doi: 10.1093/eurheartj/ehv174. Epub 2015 May 12.
Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K; SUPERB Trial Investigators. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circ Cardiovasc Interv. 2015 May;8(5):e000937. doi: 10.1161/CIRCINTERVENTIONS.113.000937.
Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL, Rihal CS, Xu K, Lei Y, Hawkey MC, Kim RJ, Alu MC, Leon MB, Mack MJ. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol. 2015 Jul 15;116(2):264-9. doi: 10.1016/j.amjcard.2015.03.061. Epub 2015 Apr 18.
Sinha SS, Julien HM, Krim SR, Ijioma NN, Baron SJ, Rock AJ, Siehr SL, Cullen MW; American College of Cardiology Fellow-in-Training Section Leadership Council. COCATS 4: Securing the Future of Cardiovascular Medicine. J Am Coll Cardiol. 2015 May 5;65(17):1907-14. doi: 10.1016/j.jacc.2015.03.015.
Chatterjee S, Herrmann HC, Wilensky RL, Hirshfeld J, McCormick D, Frankel DS, Yeh RW, Armstrong EJ, Kumbhani DJ, Giri J. Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database. JAMA Intern Med. 2015 Jul;175(7):1104-9. doi: 10.1001/jamainternmed.2015.1513.
Steinhaus DA, Waks JW, Collins R, Kleckner K, Kramer DB, Zimetbaum PJ. Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy. Am J Cardiol. 2015 Jul 1;116(1):85-7. doi: 10.1016/j.amjcard.2015.03.047. Epub 2015 Apr 8.
Ghobrial J, Gibson CM, Pinto DS. Delayed clopidogrel transit during myocardial infarction evident on angiography. J Invasive Cardiol. 2015 May;27(5):E68-9.
Steinhaus DA, Zimetbaum PJ. Update in cardiology: evidence published in 2014. Ann Intern Med. 2015 May 5;162(9):W86-90. doi: 10.7326/M15-0272.
Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015 Apr 28;131(17):1518-27. doi: 10.1161/CIRCULATIONAHA.114.014118.
Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D’Agostino RB Sr, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Jul 7;163(1):40-51. doi: 10.7326/M14-2957.
Sharma A, Ferguson C, Bainey KR. Thrombocytopenia in acute coronary syndromes: etiologies and proposed management. Can J Cardiol. 2015 Jun;31(6):809-11. doi: 10.1016/j.cjca.2014.12.034. Epub 2015 Jan 10.
Melman YF, Cutlip DE, Das S. A 54-year-old woman with a single coronary artery and watershed ischemia treated with nitrates. JACC Cardiovasc Interv. 2015 May;8(6):e91-e94. doi: 10.1016/j.jcin.2014.12.248. Epub 2015 Apr 22.
Kandzari DE, Kini AS, Karmpaliotis D, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Larracas C, Rutledge DR. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions). JACC Cardiovasc Interv. 2015 May;8(6):761-769. doi: 10.1016/j.jcin.2014.12.238. Epub 2015 Apr 22.
Shah AS, Wadwa RP, Dabelea D, Hamman RF, D’Agostino R Jr, Marcovina S, Daniels SR, Dolan LM, Fino NF, Urbina EM. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2015 Aug;16(5):367-74. doi: 10.1111/pedi.12279. Epub 2015 Apr 24.
Mallick A, Januzzi JL Jr. Biomarkers in acute heart failure. Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):514-25. doi: 10.1016/j.rec.2015.02.009. Epub 2015 Apr 21.
Secemsky EA, Matteau A, Yeh RW, Steg PG, Camenzind E, Wijns W, McFadden E, Mauri L; PROTECT Trial Investigators. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015 Jun 15;115(12):1678-84. doi: 10.1016/j.amjcard.2015.03.010. Epub 2015 Mar 23.
Henriques JP, Claessen BE, Dangas GD, Kirtane AJ, Popma JJ, Massaro JM, Cohen BM, Ohman EM, Moses JW, O’Neill WW. Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention–From the PROTECT II randomized trial. Int J Cardiol. 2015;189:272-8. doi: 10.1016/j.ijcard.2015.04.084. Epub 2015 Apr 15.
Januzzi JL Jr. What to expect when measuring high-sensitivity troponin: practical advice for clinicians. J Am Coll Cardiol. 2015 Apr 28;65(16):1665-1667. doi: 10.1016/j.jacc.2015.02.045.
Giri J, Parikh SA, Kennedy KF, Weinberg I, Donaldson C, Hawkins BM, McCormick DJ, Jackson B, Armstrong EJ, Ramchand P, White CJ, Jaff MR, Rosenfield K, Yeh RW. Proximal versus distal embolic protection for carotid artery stenting: a national cardiovascular data registry analysis. JACC Cardiovasc Interv. 2015 Apr 20;8(4):609-15. doi: 10.1016/j.jcin.2015.02.001.
Bainey KR, Patel MR, Armstrong PW. Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2015 Jun 1;115(11):1607-14. doi: 10.1016/j.amjcard.2015.02.065. Epub 2015 Mar 13.
Henry CJ, Sedjo RL, Rozhok A, Salstrom J, Ahnen D, Levin TR, D’Agostino R Jr, Haffner S, DeGregori J, Byers T. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer. 2015 Mar 14;15:123. doi: 10.1186/s12885-015-1115-2.
de Boer RA, Daniels LB, Maisel AS, Januzzi JL Jr. State of the Art: Newer biomarkers in heart failure. Eur J Heart Fail. 2015 Jun;17(6):559-69. doi: 10.1002/ejhf.273. Epub 2015 Apr 16.
Saad F, Yassin A, Haider A, Doros G, Gooren L. Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men. Korean J Urol. 2015 Apr;56(4):310-7. doi: 10.4111/kju.2015.56.4.310. Epub 2015 Mar 20.
Reynolds MR, Clem BF. Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism. Biol Chem. 2015 Aug;396(8):937-47. doi: 10.1515/hsz-2014-0307.
Min JK, Dunning A, Gransar H, Achenbach S, Lin FY, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Maffei E, Chinnaiyan K, Chow BJ, D’Agostino R, DeLago A, Friedman J, Hadamitzky M, Hausleiter J, Hayes SW, Kaufmann P, Raff GL, Shaw LJ, Thomson L, Villines T, Cury RC, Feuchtner G, Kim YJ, Leipsic J, Marques H, Berman DS, Pencina M. Medical history for prognostic risk assessment and diagnosis of stable patients with suspected coronary artery disease. Am J Med. 2015 Aug;128(8):871-8. doi: 10.1016/j.amjmed.2014.10.031. Epub 2015 Apr 10.
Rybin D, Doros G, Pencina MJ, Fava M. Placebo non-response measure in sequential parallel comparison design studies. Stat Med. 2015 Jul 10;34(15):2281-93. doi: 10.1002/sim.6494. Epub 2015 Apr 10.
Tremmel JA, Bhatt DL, Pinto DS, Grines CL. Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA. Catheter Cardiovasc Interv. 2015 Jul;86(1):73-9. doi: 10.1002/ccd.25942. Epub 2015 Apr 9.
Hawasli AH, Chang J, Reynolds MR, Ray WZ. Transfer of the brachialis to the anterior interosseous nerve as a treatment strategy for cervical spinal cord injury: technical note. Global Spine J. 2015 Apr;5(2):110-7. doi: 10.1055/s-0034-1396760. Epub 2014 Dec 15.
Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O’Connor CM, O’Gara PT, Ogedegbe O, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens. 2015 Jun;9(6):453-98. doi: 10.1016/j.jash.2015.03.002. Epub 2015 Mar 31.
Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O’Connor CM, O’Gara PT, Ogedegbe O, Oparil S, White WB; American Heart Association; American College of Cardiology; American Society of Hypertension. Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol. 2015 May 12;65(18):1998-2038. doi: 10.1016/j.jacc.2015.02.038. Epub 2015 Mar 31.
Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D’Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O’Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015 Apr 7;65(13):1314-1321. doi: 10.1016/j.jacc.2015.01.037.
Mauri L, Yeh RW, Kereiakes DJ. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 Apr 2;372(14):1373-4. doi: 10.1056/NEJMc1501195.
Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O’Connor CM, O’Gara PT, Ogedegbe G, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015 May 12;131(19):e435-70. doi: 10.1161/CIR.0000000000000207. Epub 2015 Mar 31.
Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O’Connor CM, O’Gara PT, Ogedegbe G, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension. 2015 Jun;65(6):1372-407. doi: 10.1161/HYP.0000000000000018. Epub 2015 Mar 31.
Januzzi JL, Sharma U, Zakroysky P, Truong QA, Woodard PK, Pope JH, Hauser T, Mayrhofer T, Nagurney JT, Schoenfeld D, Peacock WF, Fleg JL, Wiviott S, Pang PS, Udelson J, Hoffmann U. Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trial. Am Heart J. 2015 Apr;169(4):572-8.e1. doi: 10.1016/j.ahj.2014.12.023. Epub 2015 Jan 9.
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P, van Eickels M, Lip GY, Cohen M, Husted S, Peterson E, Fox K. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). Am Heart J. 2015 Apr;169(4):472-8.e5. doi: 10.1016/j.ahj.2014.12.006. Epub 2014 Dec 20.
Potenta SE, D’Agostino R, Sternberg KM, Tatsumi K, Perusse K. CT Urography for Evaluation of the Ureter. Radiographics. 2015 May-Jun;35(3):709-26. doi: 10.1148/rg.2015140209. Epub 2015 Mar 27.
Yeh RW, Cohen DJ, Mauri L. Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy. Eur Heart J. 2015 May 21;36(20):1216-8. doi: 10.1093/eurheartj/ehv082. Epub 2015 Mar 21.
Murphy RK, Liu B, Srinath A, Reynolds MR, Liu J, Craighead MC, Camins BC, Dhar R, Kummer TT, Zipfel GJ. No additional protection against ventriculitis with prolonged systemic antibiotic prophylaxis for patients treated with antibiotic-coated external ventricular drains. J Neurosurg. 2015 May;122(5):1120-6. doi: 10.3171/2014.9.JNS132882. Epub 2015 Mar 20.
Waldo SW, McCabe JM, O’Brien C, Kennedy KF, Joynt KE, Yeh RW. Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction. J Am Coll Cardiol. 2015 Mar 24;65(11):1119-26. doi: 10.1016/j.jacc.2015.01.008.
Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, Cutlip DE, Cohen DJ, Tanguay JF, Jacobs A, Wiviott SD, Massaro JM, Iancu AC, Mauri L; DAPT Study Investigators. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15.
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671.
Motiwala SR, Gaggin HK, Gandhi PU, Belcher A, Weiner RB, Baggish AL, Szymonifka J, Januzzi JL Jr. Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure. J Cardiovasc Transl Res. 2015 Apr;8(3):164-72. doi: 10.1007/s12265-015-9618-4. Epub 2015 Mar 17.
Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16.
Kobayashi N, Maehara A, Mintz GS, Wolff SD, Généreux P, Xu K, Mehran R, Gibson CM, Brener SJ, Stone GW. Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy). Am J Cardiol. 2015 May 15;115(10):1389-95. doi: 10.1016/j.amjcard.2015.02.034. Epub 2015 Feb 19.
Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER 3rd, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Jaff MR, Comerota AJ, Steffes MW, Abrahamsen IH, Goldberg S, Hirsch AT. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015 Mar 17;65(10):999-1009. doi: 10.1016/j.jacc.2014.12.043.
Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Lam H, White WB; EXAMINE Investigators. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet. 2015 May 23;385(9982):2067-76. doi: 10.1016/S0140-6736(14)62225-X. Epub 2015 Mar 10.
Vassiliades TA, Adams DH, Popma JJ. Two cases of heart failure after implantation of a CoreValve prosthesis. N Engl J Med. 2015 Mar 12;372(11):1080-1. doi: 10.1056/NEJMc1409305.
Gandhi PU, Gaggin HK, Belcher AM, Harisiades JE, Basile A, Falco A, Rosati A, Piscione F, Januzzi JL Jr, Turco MC. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure. Clin Chim Acta. 2015 May 20;445:73-8. doi: 10.1016/j.cca.2015.02.048. Epub 2015 Mar 6.
Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield M, Devlin JJ, Nordio F, Hyde C, Cannon CP, Sacks F, Poulter N, Sever P, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015 Jun 6;385(9984):2264-2271. doi: 10.1016/S0140-6736(14)61730-X. Epub 2015 Mar 4.
Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015 Mar 10;65(9):931-41. doi: 10.1016/j.jacc.2014.12.036.
Navar-Boggan AM, Peterson ED, D’Agostino RB Sr, Pencina MJ, Sniderman AD. Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. J Am Coll Cardiol. 2015 Apr 28;65(16):1633-1639. doi: 10.1016/j.jacc.2015.02.025. Epub 2015 Mar 2.
Shah AS, Black S, Wadwa RP, Schmiege SJ, Fino NF, Talton JW, D’Agostino R Jr, Hamman RF, Urbina EM, Dolan LM, Daniels SR, Marcovina SM, Dabelea D. Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. J Diabetes Complications. 2015 May-Jun;29(4):512-6. doi: 10.1016/j.jdiacomp.2015.02.004. Epub 2015 Feb 14.
Lupón J, Gaggin HK, de Antonio M, Domingo M, Galán A, Zamora E, Vila J, Peñafiel J, Urrutia A, Ferrer E, Vallejo N, Januzzi JL, Bayes-Genis A. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score. Int J Cardiol. 2015 Apr 1;184:337-343. doi: 10.1016/j.ijcard.2015.02.019. Epub 2015 Feb 17.
Patti G, Bennett R, Seshasai SR, Cannon CP, Cavallari I, Chello M, Nusca A, Mega S, Caorsi C, Spadaccio C, Keun On Y, Mannacio V, Berkan O, Yilmaz MB, Katrancioglu N, Ji Q, Kourliouros A, Baran Ç, Pasceri V, Rüçhan Akar A, Carlos Kaski J, Di Sciascio G, Ray KK. Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. Europace. 2015 Jun;17(6):855-63. doi: 10.1093/europace/euv001. Epub 2015 Mar 1.
Tahir U, Doros G, Sam F. Delayed myocardial recovery in peripartum cardiomyopathy. Int J Cardiol. 2015 Apr 1;184:310-312. doi: 10.1016/j.ijcard.2015.02.064. Epub 2015 Feb 24.
Gandhi PU, Motiwala SR, Belcher AM, Gaggin HK, Weiner RB, Baggish AL, Fiuzat M, Brunner-La Rocca HP, Januzzi JL Jr. Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction. Am Heart J. 2015 Mar;169(3):404-411.e3. doi: 10.1016/j.ahj.2014.12.012. Epub 2015 Jan 7.
Plent S, Fan W, Kirtane A, Brener SJ, Genereux P, Mehran R, Pinto DS, McEntegart M, Cohen DJ, Stone GW. Cost implications of intraprocedural thrombotic events during PCI. Catheter Cardiovasc Interv. 2015 Jul;86(1):30-9. doi: 10.1002/ccd.25909. Epub 2015 Mar 25.
Abizaid A, Costa JR Jr, Gibson CM. Bioresorbable vascular scaffolds in daily clinical practice: is the essential really invisible to the eyes?. J Am Coll Cardiol. 2015 Mar 3;65(8):802-804. doi: 10.1016/j.jacc.2014.12.016.
Yeh RW, Mauri L, Kereiakes DJ. Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected]. J Am Coll Cardiol. 2015 Mar 3;65(8):787-790. doi: 10.1016/j.jacc.2015.01.004.
White HD, Bhatt DL, Gibson CM, Hamm CW, Mahaffey KW, Price MJ, Steg PG, Stone GW, Cortese B, Wilensky M, Deliargyris EN, Liu T, Prats J, Harrington RA. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). JACC Cardiovasc Interv. 2015 Mar;8(3):424-433. doi: 10.1016/j.jcin.2014.09.025. Epub 2015 Feb 18.
Cutlip DE, Kereiakes DJ, Mauri L, Stoler R, Dauerman HL; EDUCATE Investigators. Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy. JACC Cardiovasc Interv. 2015 Mar;8(3):404-410. doi: 10.1016/j.jcin.2014.10.017. Epub 2015 Feb 18.
Kapadia S, Stewart WJ, Anderson WN, Babaliaros V, Feldman T, Cohen DJ, Douglas PS, Makkar RR, Svensson LG, Webb JG, Wong SC, Brown DL, Miller DC, Moses JW, Smith CR, Leon MB, Tuzcu EM. Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). JACC Cardiovasc Interv. 2015 Feb;8(2):324-333. doi: 10.1016/j.jcin.2014.08.015.
Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ; CoreValve U.S. Trial Investigators. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb;8(2):315-323. doi: 10.1016/j.jcin.2014.08.016.
Cannon CP, Cariou B, Blom D, McKenney JM, Lorenzato C, Pordy R, Chaudhari U, Colhoun HM; ODYSSEY COMBO II Investigators. Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. Eur Heart J. 2015 May 14;36(19):1186-94. doi: 10.1093/eurheartj/ehv028. Epub 2015 Feb 16.
Chong CC, Tan TW, Abreo K, Pahilan ME, Rybin D, Doros G, Zhang WW, Farber A. Laparoscopic peritoneal dialysis catheter placement is associated with decreased deep organ infection and reoperation. Clin Nephrol. 2015 Mar;83(3):161-6. doi: 10.5414/cn108442.
Généreux P, Kumsars I, Lesiak M, Kini A, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. J Am Coll Cardiol. 2015 Feb 17;65(6):533-43. doi: 10.1016/j.jacc.2014.11.031.
Healey KM, Combs DR, Gibson CM, Keefe RS, Roberts DL, Penn DL. Observable Social Cognition–A Rating Scale: an interview-based assessment for schizophrenia. Cogn Neuropsychiatry. 2015;20(3):198-221. doi: 10.1080/13546805.2014.999915. Epub 2015 Feb 13.
Januzzi JL, Pascual-Figal D, Daniels LB. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel. Am J Cardiol. 2015 Apr 2;115(7 Suppl):70B-5B. doi: 10.1016/j.amjcard.2015.01.044. Epub 2015 Jan 24.
Brinton EA, Kher U, Shah S, Cannon CP, Davidson M, Gotto AM, Ashraf TB, McCrary Sisk C, Dansky H, Mitchel Y, Barter P; DEFINE Investigators. Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial. J Clin Lipidol. 2015 Jan-Feb;9(1):65-71. doi: 10.1016/j.jacl.2014.10.005. Epub 2014 Nov 4.
Pascual-Figal DA, Januzzi JL. The biology of ST2: the International ST2 Consensus Panel. Am J Cardiol. 2015 Apr 2;115(7 Suppl):3B-7B. doi: 10.1016/j.amjcard.2015.01.034. Epub 2015 Jan 23.
Bajwa EK, Mebazaa A, Januzzi JL. ST2 in Pulmonary Disease. Am J Cardiol. 2015 Apr 2;115(7 Suppl):44B-7B. doi: 10.1016/j.amjcard.2015.01.040. Epub 2015 Jan 23.
Januzzi JL, Mebazaa A, Di Somma S. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel. Am J Cardiol. 2015 Apr 2;115(7 Suppl):26B-31B. doi: 10.1016/j.amjcard.2015.01.037. Epub 2015 Jan 23.
Bayes-Genis A, Januzzi JL. The International ST2 Consensus Panel: Introduction. Am J Cardiol. 2015 Apr 2;115(7 Suppl):1B-2B. doi: 10.1016/j.amjcard.2015.01.033. Epub 2015 Jan 23.
Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. Epub 2015 Feb 6.
Chotenimitkhun R, D’Agostino R Jr, Lawrence JA, Hamilton CA, Jordan JH, Vasu S, Lash TL, Yeboah J, Herrington DM, Hundley WG. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Can J Cardiol. 2015 Mar;31(3):302-7. doi: 10.1016/j.cjca.2014.11.020. Epub 2014 Nov 26.
Flores-Blanco PJ, López-Cuenca Á, Januzzi JL, Marín F, Sánchez-Martínez M, Quintana-Giner M, Romero-Aniorte AI, Valdés M, Manzano-Fernández S. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome. Eur J Clin Invest. 2015 Apr;45(4):385-93. doi: 10.1111/eci.12418. Epub 2015 Mar 9.
Cowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-Ray L, Nikolic E, Janzon M, Levin LÅ, Cannon CP, Harrington RA, Mark DB. Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study. J Am Coll Cardiol. 2015 Feb 10;65(5):465-76. doi: 10.1016/j.jacc.2014.11.034.
Suarez L, Beach SR, Moore SV, Mastromauro CA, Januzzi JL, Celano CM, Chang TE, Huffman JC. Use of the Patient Health Questionnaire-9 and a detailed suicide evaluation in determining imminent suicidality in distressed patients with cardiac disease. Psychosomatics. 2015 Mar-Apr;56(2):181-9. doi: 10.1016/j.psym.2014.12.005. Epub 2014 Dec 19.
De Luca G, Van’t Hof AW, Gibson CM, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel HM, Emre A, Rakowski T, Gyongyosi M, Huber K, Bellandi F, Dudek D; EGYPT cooperation. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Am J Cardiol. 2015 Mar 15;115(6):711-5. doi: 10.1016/j.amjcard.2014.12.030. Epub 2015 Jan 6.
Xu W, Goldberg SI, Shubina M, Turchin A. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015 Feb 5;350:h158. doi: 10.1136/bmj.h158.
Reed GW, Kumar A, Guo J, Aranki S, Shekar P, Agnihotri A, Maree AO, McLean DS, Rosenfield K, Cannon CP. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45–a pilot study. Clin Cardiol. 2015 Feb;38(2):92-8. doi: 10.1002/clc.22357. Epub 2015 Feb 5.
Carroll JD, Shuren J, Jensen TS, Hernandez J, Holmes D, Marinac-Dabic D, Edwards FH, Zuckerman BD, Wood LL, Kuntz RE, Mack MJ. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Aff (Millwood). 2015 Feb;34(2):328-34. doi: 10.1377/hlthaff.2014.1010.
Garg P, Galper BZ, Cohen DJ, Yeh RW, Mauri L. Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents. Am Heart J. 2015 Feb;169(2):222-233.e5. doi: 10.1016/j.ahj.2014.11.002. Epub 2014 Nov 10.
Allen KB, Davis JR, Cohen DJ. Critical aortic stenosis and acute ascending aortic penetrating ulcer managed utilizing transapical TAVR and TEVAR. Catheter Cardiovasc Interv. 2015 Oct;86(4):768-72. doi: 10.1002/ccd.25816. Epub 2015 Feb 3.
Uthamalingam S, Kandala J, Selvaraj V, Martin W, Daley M, Patvardhan E, Capodilupo R, Moore S, Januzzi JL Jr. Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists. Am J Cardiol. 2015 Feb 15;115(4):466-71. doi: 10.1016/j.amjcard.2014.11.034. Epub 2014 Dec 2.
Pencina MJ, D’Agostino RB, Zdrojewski T, Williams K, Thanassoulis G, Furberg CD, Peterson ED, Vasan RS, Sniderman AD. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. Eur J Prev Cardiol. 2015 Oct;22(10):1321-7. doi: 10.1177/2047487315569411. Epub 2015 Jan 29.
Navar-Boggan AM, Peterson ED, D’Agostino RB Sr, Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015 Feb 3;131(5):451-8. doi: 10.1161/CIRCULATIONAHA.114.012477. Epub 2015 Jan 26.
Veiner HL, Gorbatov R, Vardi M, Doros G, Miller-Lotan R, Zohar Y, Sabo E, Asleh R, Levy NS, Goldfarb LJ, Berk TA, Haas T, Shalom H, Suss-Toby E, Kam A, Kaplan M, Tamir R, Ziskind A, Levy AP. Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability. Atherosclerosis. 2015 Mar;239(1):232-9. doi: 10.1016/j.atherosclerosis.2015.01.008. Epub 2015 Jan 14.
Kalish J, Eslami M, Gillespie D, Schermerhorn M, Rybin D, Doros G, Farber A; Vascular Study Group of New England. Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates. J Vasc Surg. 2015 May;61(5):1231-8. doi: 10.1016/j.jvs.2014.12.003. Epub 2015 Jan 13.
Friões F, Lourenço P, Laszczynska O, Almeida PB, Guimarães JT, Januzzi JL, Azevedo A, Bettencourt P. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin Res Cardiol. 2015 Jun;104(6):491-9. doi: 10.1007/s00392-015-0811-x. Epub 2015 Jan 14.
Dohi T, Maehara A, Brener SJ, Généreux P, Gershlick AH, Mehran R, Gibson CM, Mintz GS, Stone GW. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol. 2015 Mar 1;115(5):563-70. doi: 10.1016/j.amjcard.2014.12.008. Epub 2014 Dec 18.
Passeri JJ, Elmariah S, Xu K, Inglessis I, Baker JN, Alu M, Kodali S, Leon MB, Svensson LG, Pibarot P, Fearon WF, Kirtane AJ, Vlahakes GJ, Palacios IF, Douglas PS; PARTNER Investigators. Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF. Heart. 2015 Mar;101(6):463-71. doi: 10.1136/heartjnl-2014-306737. Epub 2015 Jan 13.
Yeh RW, Mauri L, Wolf RE, Romm IK, Lovett A, Shahian D, Normand SL. Population trends in rates of coronary revascularization. JAMA Intern Med. 2015 Mar;175(3):454-6. doi: 10.1001/jamainternmed.2014.7129.
Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol. 2015 Jul 28;66(4):403-69. doi: 10.1016/j.jacc.2014.12.018. Epub 2014 Dec 29.
Majithia A, Reynolds MR. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: rarely a good value. Europace. 2015 Jan;17(1):5-6. doi: 10.1093/europace/euu316.
Berry D, Mader E, Lee TK, Woebken D, Wang Y, Zhu D, Palatinszky M, Schintlmeister A, Schmid MC, Hanson BT, Shterzer N, Mizrahi I, Rauch I, Decker T, Bocklitz T, Popp J, Gibson CM, Fowler PW, Huang WE, Wagner M. Tracking heavy water (D2O) incorporation for identifying and sorting active microbial cells. Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E194-203. doi: 10.1073/pnas.1420406112. Epub 2014 Dec 30.
Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL; American College of Cardiology; American Heart Association. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015 Jul 28;132(4):302-61. doi: 10.1161/CIR.0000000000000156. Epub 2014 Dec 29.
Culler SD, Kugelmass AD, Brown PP, Reynolds MR, Simon AW. Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012. Circulation. 2015 Jan 27;131(4):362-70; discussion 370. doi: 10.1161/CIRCULATIONAHA.114.012485. Epub 2014 Dec 22.
Gibson CM, Havenith RW, Fowler PW, Jenneskens LW. Planar homotropenylium cation: a transition state with reversed aromaticity. J Org Chem. 2015 Feb 6;80(3):1395-401. doi: 10.1021/jo502179k. Epub 2015 Jan 9.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
Sherwood MW, Brennan JM, Ho KK, Masoudi FA, Messenger JC, Weaver WD, Dai D, Peterson ED. The impact of extreme-risk cases on hospitals’ risk-adjusted percutaneous coronary intervention mortality ratings. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):10-6. doi: 10.1016/j.jcin.2014.07.025. Epub 2014 Dec 10.
Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Gold A. Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. Am Heart J. 2015 Jan;169(1):186-7. doi: 10.1016/j.ahj.2014.09.004. Epub 2014 Sep 19.
Koshizaka M, Lopes RD, Reyes EM, Gibson CM, Schulte PJ, Hafley GE, Hernandez AF, Green JB, Kouchoukos NT, Califf RM, Ferguson TB, Peterson ED, Alexander JH. Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. Am Heart J. 2015 Jan;169(1):175-84. doi: 10.1016/j.ahj.2014.10.013. Epub 2014 Oct 23.
Lytle BL, Li S, Lofthus DM, Thomas L, Poteat JL, Bhatt DL, Cannon CP, Fonarow GC, Peterson ED, Wang TY, Alexander KP. Targeted versus standard feedback: results from a randomized quality improvement trial. Am Heart J. 2015 Jan;169(1):132-41.e2. doi: 10.1016/j.ahj.2014.08.017. Epub 2014 Oct 22.
Tomey MI, Mehran R, Brener SJ, Maehara A, Witzenbichler B, Dizon JM, El-Omar M, Xu K, Gibson CM, Stone GW. Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). Am Heart J. 2015 Jan;169(1):86-93. doi: 10.1016/j.ahj.2014.06.019. Epub 2014 Jul 3.
Kumar A, Matheny ME, Ho KK, Yeh RW, Piemonte TC, Waldman H, Shah PB, Cope R, Normand SL, Donnelly S, Robbins S, Resnic FS. The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):38-46. doi: 10.1161/CIRCOUTCOMES.114.001123. Epub 2014 Dec 9.
De Berardinis B, Gaggin HK, Magrini L, Belcher A, Zancla B, Femia A, Simon M, Motiwala S, Bhardwaj A, Parry BA, Nagurney JT, Coudriou C, Legrand M, Sadoune M, Di Somma S, Januzzi JL Jr; Global Research on Acute Conditions Team (GREAT). Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin Chem Lab Med. 2015 Mar;53(4):613-21. doi: 10.1515/cclm-2014-0191.
Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR; IN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015 Feb 3;131(5):495-502. doi: 10.1161/CIRCULATIONAHA.114.011004. Epub 2014 Dec 3.
Elmariah S, Mauri L, Doros G, Galper BZ, O’Neill KE, Steg PG, Kereiakes DJ, Yeh RW. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. Lancet. 2015 Feb 28;385(9970):792-8. doi: 10.1016/S0140-6736(14)62052-3. Epub 2014 Nov 16.
Gandhi PU, Szymonifka J, Motiwala SR, Belcher AM, Januzzi JL Jr, Gaggin HK. Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the pro-B-type natriuretic peptide outpatient-tailored chronic heart failure therapy (PROTECT) study. J Card Fail. 2015 Jan;21(1):9-15. doi: 10.1016/j.cardfail.2014.10.008. Epub 2014 Oct 18.
Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ, Januzzi JL, Pascual-Figal DA. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 2015 Jan;3(1):50-58. doi: 10.1016/j.jchf.2014.07.015. Epub 2014 Nov 12.
Eslami MH, Rybin D, Doros G, Farber A. Open repair of asymptomatic popliteal artery aneurysm is associated with better outcomes than endovascular repair. J Vasc Surg. 2015 Mar;61(3):663-9. doi: 10.1016/j.jvs.2014.09.069. Epub 2014 Nov 6.
Bayes-Genis A, Januzzi JL, Gaggin HK, de Antonio M, Motiwala SR, Zamora E, Galán A, Domingo M, Urrutia A, Lupón J. ST2 pathogenetic profile in ambulatory heart failure patients. J Card Fail. 2015 Apr;21(4):355-61. doi: 10.1016/j.cardfail.2014.10.014. Epub 2014 Nov 3.
Ahmad T, Wang T, O’Brien EC, Samsky MD, Pura JA, Lokhnygina Y, Rogers JG, Hernandez AF, Craig D, Bowles DE, Milano CA, Shah SH, Januzzi JL, Felker GM, Patel CB. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail. 2015 Jan;3(1):30-39. doi: 10.1016/j.jchf.2014.06.013. Epub 2014 Nov 12.
Lupón J, Januzzi JL, de Antonio M, Vila J, Peñafilel J, Bayes-Genis A. Validation of the Barcelona Bio-Heart Failure Risk Calculator in a cohort from Boston. Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):80-1. doi: 10.1016/j.rec.2014.08.009. Epub 2014 Nov 29.
Maisel A, Xue Y, Greene SJ, Pang PS, Januzzi JL, Piña IL, DeFilippi C, Butler J. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. J Card Fail. 2015 Mar;21(3):233-9. doi: 10.1016/j.cardfail.2014.11.009. Epub 2014 Nov 26.
Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. Am J Med. 2015 Apr;128(4):426.e1-9. doi: 10.1016/j.amjmed.2014.11.013. Epub 2014 Nov 26.
Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O’Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015 Jan 21;36(4):219-27. doi: 10.1093/eurheartj/ehu441. Epub 2014 Nov 16.
Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement. Circulation. 2015 Jan 6;131(1):62-73. doi: 10.1161/CIRCULATIONAHA.114.013570. Epub 2014 Nov 16.
Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR Jr, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16.
Underwood P, Seiden J, Carbone K, Chamarthi B, Turchin A, Bader AM, Garg R. Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1C Testing in the Preoperative Period. Endocr Pract. 2015 Mar;21(3):231-6. doi: 10.4158/EP14228.OR.
Rybin D, Doros G, Rosenheck R, Lew R. The impact of missing data on the results of a schizophrenia study. Pharm Stat. 2015 Jan-Feb;14(1):4-10. doi: 10.1002/pst.1651. Epub 2014 Oct 18.
Cavender MA, Gibson CM, Braunwald E, Wiviott SD, Murphy SA, Toda Kato E, Plotnikov AN, Amuchástegui M, Oude Ophuis T, van Hessen M, Mega JL. The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 – TIMI 51 trial. Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):468-74. doi: 10.1177/2048872614554109. Epub 2014 Oct 15.
Margheri F, Papucci L, Schiavone N, D’Agostino R, Trigari S, Serratì S, Laurenzana A, Biagioni A, Luciani C, Chillà A, Andreucci E, Del Rosso T, Margheri G, Del Rosso M, Fibbi G. Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. J Cell Mol Med. 2015 Jan;19(1):113-23. doi: 10.1111/jcmm.12410. Epub 2014 Oct 14.
Eslami MH, Doros G, Goodney PP, Elderup-Jorgenson J, Cronenwett JL, Malikova M, Farber A. Using vascular quality initiative as a platform for organizing multicenter, prospective, randomized clinical trials: OVERPAR trial. Ann Vasc Surg. 2015 Feb;29(2):278-85. doi: 10.1016/j.avsg.2014.08.007. Epub 2014 Oct 12.
Ducrocq G, Schulte PJ, Becker RC, Cannon CP, Harrington RA, Held C, Himmelmann A, Lassila R, Storey RF, Sorbets E, Wallentin L, Steg PG. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial. EuroIntervention. 2015 Nov;11(7):737-45. doi: 10.4244/EIJY14M09_11.
Hamnvik OP, Choueiri TK, Turchin A, McKay RR, Goyal L, Davis M, Kaymakcalan MD, Williams JS. Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway. Cancer. 2015 Jan 15;121(2):311-9. doi: 10.1002/cncr.28972. Epub 2014 Sep 18.
Reynolds MR, Crilly SM, Sweeney KJ, Farrell M, Rawluk D. Metastatic pancreatic neuroendocrine tumor to the central nervous system in a patient with von Hippel-Lindau disease: A case report and literature review. Br J Neurosurg. 2015 Apr;29(2):291-3. doi: 10.3109/02688697.2014.957650. Epub 2014 Sep 18.
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart. 2015 Jan;101(2):119-25. doi: 10.1136/heartjnl-2014-305864. Epub 2014 Sep 16.
Reid KF, Martin KI, Doros G, Clark DJ, Hau C, Patten C, Phillips EM, Frontera WR, Fielding RA. Comparative effects of light or heavy resistance power training for improving lower extremity power and physical performance in mobility-limited older adults. J Gerontol A Biol Sci Med Sci. 2015 Mar;70(3):374-80. doi: 10.1093/gerona/glu156. Epub 2014 Sep 8.
Reynolds MR, Sweeney KJ, Crilly SM, Farrell M, Jaffe ES, Javadpour M. Rapid, de novo development of isolated intracranial rosai-dorfman disease: A case report. Br J Neurosurg. 2015 Feb;29(1):82-84. doi: 10.3109/02688697.2014.950634. Epub 2014 Aug 21.
Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Catheter Cardiovasc Interv. 2015 Mar;85(4):544-53. doi: 10.1002/ccd.25629. Epub 2014 Aug 28.
Tremmel JA, Patel RA, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):95-103. doi: 10.1002/ccd.25635. Epub 2014 Oct 4.
Sharma R, Bainey KR. The role of the novel oral anticoagulants in the secondary prevention of acute coronary syndromes. Cardiol Rev. 2015 Mar-Apr;23(2):99-102. doi: 10.1097/CRD.0000000000000029.
Steyerberg EW, Vedder MM, Leening MJ, Postmus D, D’Agostino RB Sr, Van Calster B, Pencina MJ. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives. Biom J. 2015 Jul;57(4):556-70. doi: 10.1002/bimj.201300260. Epub 2014 Jul 18.
Elmariah S, Mutrie CJ, Mehrotra P, Carter B, Drachman DE, Walker JD. Percutaneous extraction of pacing leads from the left coronary artery and left ventricle. EuroIntervention. 2015 Jul 22;11(3):e1-2. doi: 10.4244/EIJY14M07_07.
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan;39(1):55-9. doi: 10.1007/s11239-014-1101-6.
Haider A, Zitzmann M, Doros G, Isbarn H, Hammerer P, Yassin A. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. J Urol. 2015 Jan;193(1):80-6. doi: 10.1016/j.juro.2014.06.071. Epub 2014 Jun 26.
Hua SY, Xu S, D’Agostino RB Sr. Multiplicity adjustments in testing for bioequivalence. Stat Med. 2015 Jan 30;34(2):215-31. doi: 10.1002/sim.6247. Epub 2014 Jul 1.
Lustgarten S, Doros G. Nonparametric Prediction of Event Times for Analysis of Failure-Time Data. J Biopharm Stat. 2015;25(4):695-713. doi: 10.1080/10543406.2014.920853.
Gandhi PU, Januzzi JL Jr. Can copeptin emerge from the growing shadow of the troponins?. Eur Heart J. 2015 Feb 7;36(6):333-6. doi: 10.1093/eurheartj/ehu211. Epub 2014 May 20.
Paul L, Jacques PF, Aviv A, Vasan RS, D’Agostino RB, Levy D, Selhub J. High plasma folate is negatively associated with leukocyte telomere length in Framingham Offspring cohort. Eur J Nutr. 2015 Mar;54(2):235-41. doi: 10.1007/s00394-014-0704-1. Epub 2014 May 3.
Celik T, Kaya MG, Akpek M, Gunebakmaz O, Balta S, Sarli B, Duran M, Demirkol S, Uysal OK, Oguzhan A, Gibson CM. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology. 2015 Feb;66(2):155-62. doi: 10.1177/0003319713513493. Epub 2013 Dec 3.